Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Hexagon Composites ASA (OSE:HEX) will report its 2020 first quarter results on 20 May 2020 via a livestream

Quarterly earnings release: Time: Wednesday, 20 May 2020 at 07:00 CEST Interim report and presentation material will be released and made available on www.hexagongroup.com and www.newsweb.no Results presentation: Time: Wednesday, 20 May 2020 at 08:30 CEST Format: Live stream Language: English The company will be represented by: Group President & CEO, Jon Erik Engeset CFO, David Bandele The presentation will be broadcast live on www.hexagongroup.com at 08:30 CEST. A recording of the presentation will be available on our website after the presentation. For

InCoax Networks AB has received Tillväxtverket's approval of grants for so called “short-term work”, which now have been implemented

InCoax Networks AB today announces that the company has received Tillväxtverket's approval of grants for so called “short-term work” (Sw. korttidsarbete), which now have been implemented.”As a result of the ongoing covid-19 pandemic, Tillväxtverket has approved InCoax Network's application for grants for short-term work. Based on this, individual agreements have been made with approximately 75% of the employees working two days a week up to 2020-08-05. The company is also continuing its work to identify additional cost savings in its operations, which will be implemented successively, but

Scania Interim Report January–March 2020

The first quarter of 2020 started in a positive way but was from March dominated by the coronavirus outbreak and the extraordinary social measures taken to reduce the spread of infection.Summary of the first three months of 2020 · Net sales fell by 8 percent to SEK 33,051 m. (36,092) · Operating income fell by 29 percent to SEK 3,005 m. (4,207) · Cash flow amounted to SEK 1,441 m. (507) in Vehicles and Services  Comments by Henrik Henriksson, President and CEO “The first quarter of 2020 started in a positive way but was from March dominated by the coronavirus outbreak and

New Company in the LFV Holding Group

As of April 30, 2020, LFV has finalized the acquisition of Eltel's Aviation & Security business area. In June 2019 a letter of intent was signed between the parties and the transfer of shares is now completed. The newly formed company will be part of the LFV holding group.- With the new company in place, they will manage the operation and maintenance of our systems under our own control. The company will also continue to provide technical services to both current and new customers. At the same time, the company will contribute to the development of LFV's operations. I welcome Robert

Presentation of 1Q 2020 results

Otello Corporation ASA (the "Company") is presenting its 1Q 2020 results on Thursday, May 7, 2020, at 08:00am CET. Due to the ongoing Covid-19 pandemic, the Company will not invite to a meeting with physical presence. Rather, the results will be released at 07:00am CET and an live audiocast of the presentation will be held at 08:00am CET, which will be available at: https://otellocorp.com/ir It will be possible to raise questions during the audiocast.Petter Lade, CFO Phone: +47 91143878 E-mail: petterl@otellocorp.com About Otello: Otello holds shares in several different

Trachtenberg tells Jane’s: “Fireworks” expected between defence spending and other priorities, as supply chain reels from Covid-19 impact

First instalment of Jane’s Defence Industry Conversations sees Hon. David Trachtenberg discuss the impact of Covid-19 on US defence priorities, while defence budgets data from Jane’s reflects the likely squeeze on military spendingLONDON (4 May 2020) –– Speaking in Jane’s inaugural Defence Industry Conversation,  Hon. David Trachtenberg reinforced the need to work together in order to protect US security interests in light of Covid-19. The new webinar

Drinking water purification gives consumers full control

It is virtually impossible for private citizens to influence the quality of their local, municipally supplied drinking water. But by installing water purification systems in their own homes - either at the main line or directly at the tap - consumers can regain control of their drinking water.Globally, mistrust of drinking water and public water supply is growing. Many consumers are reluctant to drink water directly from the tap because they do not trust it to be clean. According to figures from the European Commission 

NOTICE OF EXTRA GENERAL MEETING IN EMBRACER GROUP AB

The shareholders of Embracer Group AB, reg. no. 556582-6558, (the "Company") are hereby invited to the extra general meeting on Wednesday 20 May 2020 at 08.30 am CET at Baker McKenzie''s premises at Vasagatan 7 in Stockholm. The doors to the meeting will open at 08.15 am CET.Information with respect to the coronavirus Due to the development of the coronavirus the goal is that the extra general meeting shall be swift and effective to minimize spread of disease. Shareholders should carefully consider the possibility to vote in advance, please see below, as well as the possibility of

IRRAS receives approval for loan from US Stimulus Package

Stockholm, May 4[th], 2020 – IRRAS, a global medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced that it entered into an unsecured promissory note under the Paycheck Protection Program (the “PPP”) for a principal amount of USD 832,055. The PPP was established under the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) that was recently approved by the United States Congress to provide a USD 2.2 trillion package that allocates funding to small businesses to stimulate the economy and help businesses

Clinical report shows effective long term performance of the e-OPRA™ Implant System

Introducing one of the world’s most integrated interfaces between man and machineWhile there are several centers pursuing research in developing a natural and intuitively controlled robotic prosthesis, very few researchers have been successful in developing a system that can be translated into real-life settings, outside the laboratories or controlled environments in the long term. To this end, Integrum AB introduced the e-OPRA Implant system with the first surgery in 2013, where the OPRA[TM] Implant System was upgraded with the addition of neuromuscular electrodes, permanently implanted in

NetEnt debuts their games in the Croatian regulated market

NetEnt continues to make headway in to regulated markets. Now players in Croatia can enjoy NetEnt’s portfolio of renowned slot games and marketing tools with market leading operators SuperSport, Germania and Arena Casino.With the entries into both Switzerland and Colombia last month, Croatia is the latest regulated market where NetEnt games are now available. The first operators to go live with NetEnt games is SuperSport, Germania and Arena Casino, leading operators in the Croatian online gaming market. Now their players can enjoy NetEnt award-winning slot as well as marketing tools to help

SRV commences written procedures to amend terms of its senior unsecured notes

SRV GROUP PLC     INSIDE INFORMATION    4 MAY 2020     10.30 EET SRV commences written procedures to amend terms of its senior unsecured notes SRV Group Plc (“SRV”) announced on 27 April 2020 discussions with the holders of its EUR 100,000,000 (of which EUR 62,1 million is outstanding) senior unsecured callable fixed rate notes due 23 March 2021 (the “2021 Notes”) and its EUR 75,000,000 senior unsecured callable fixed rate notes due 27 March 2022 (the “2022 Notes” and together with the 2021 Notes, the “Senior Notes”) regarding potential amendments to the terms and conditions of the

Medium-term contracts for multiple vessels

Solstad Offshore ASA has entered into medium-term contracts for six of its vessels for a period of 80 to 170 days each with undisclosed Clients. Commencement will be around July 1[st] and the operation are outside the North Sea. The nominated vessels are the PSVs Normand Supra, Normand Surfer, Normand Serenade, Normand Sitella and Sea Spear, in addition to the AHTS Far Sigma. The contracts will significantly reduce the company’s North Sea spot market exposure in 2020. Skudeneshavn, May 4[th], 2020 ContactsLars Peder Solstad CEO, at +47 91 31 85 85Anders Hall Jomaas CFO, at

ANNOUNCEMENT OF THE NAV OF PROVENTUS CAPITAL PARTNERS II

Press release Stockholm, 4 May 2020 ANNOUNCEMENT OF THE NAV OF PROVENTUS CAPITAL PARTNERS II Since Proventus Capital Partners II decreased its contributed capital by SEK 63 million through a repayment to debenture holders and owners, the Net Asset Value of the Proventus Capital Partners II participation loan has been calculated. The Net Asset Value is to be calculated at the close of each quarter and in conjunction with a capital increase or decrease. The repayment amounted to SEK 6,000 per debenture and SEK 12 million to the owners. At the close of business on 30 April 2020,

ANNOUNCEMENT OF THE NAV OF PROVENTUS CAPITAL PARTNERS III

Press release Stockholm, 4 May 2020 Announcement of the NAV of proventus capital partners iii Since Proventus Capital Partners III decreased its contributed capital by SEK 219 million through a repayment to debenture holders and owners, the Net Asset Value of the Proventus Capital Partners III participation loan has been calculated. The Net Asset Value is to be calculated at the close of each quarter and in conjunction with a capital increase or decrease. The repayment amounted to SEK 19,000 per Series A participation loan debenture, SEK 475,000 per Series B participation loan

Väderstad makes QuickStart movies available in the E-Control app

By releasing a new free update of the app for the iPad-based control system Väderstad E-Control, Väderstad increases the user experience in the field. Now, the farmer can find and download manuals, spare part documentation and QuickStart movies integrated in the control system.- To always have updated guides, manuals and instructional movies available when needed at the machine in the field, is a great support for the farmer, says Mattias Hovnert, Senior Vice President Sales & Marketing, at Väderstad, and continues: - Whether it comes to calibration of the machine, connecting to the

The Applications of AI in life science

Artificial Intelligence is having a big impact on the life science sector. Diagnosing and treating patients is becoming more effective thanks to AI, and pharma companies are relying on the up-and-coming technology to speed up their drug discovery projects. In this second article in BioStock’s article series on AI, we take a closer look at the general impact of AI in life science.  Read the full article at BioStock.se: https://www.biostock.se/2020/05/the-applications-of-ai-in-life-science/

Presentation of Polygon first quarter 2020 report

On Tuesday May 5, 2020 at 08.00 CET, Polygon AB (publ) will publish its first quarter 2020 report.Financial analysts and investors in Polygon senior secured notes are invited to participate in a telephone conference on the same day at 11:00 CET where the Q1 report will be presented. The event will be hosted by Polygon´s CEO Axel Gränitz and CFO Martin Hamner. The presentation will be held in English. Slides for the presentation will be made available on our website https://www.polygongroup.com/investors/financial-reports/ prior to the start of the conference. To participate in the

ExpreS2ion announces supporting an advantageous COVID-19 diagnostic antibody development project

Hørsholm, Denmark, May 4, 2020 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, announces that its SARS-CoV-2 antigen is being applied across multiple research and development projects, including an on-going diagnostic antibody test program that Rigshospitalet, University of Copenhagen and Novo Nordisk jointly develop to support the diagnosis of COVID-19 in Denmark on a national level.ExpreS[2]ion and its joint venture partner AdaptVac are engaged in the development of a unique capsid virus-like particle (VLP) COVID-19

UPM-Kymmene Corporation: Managers’ Transactions (Oudeman)

UPM-Kymmene Corporation       Stock Exchange Release (Managers' Transactions) 4 May 2020 at 09:45 EET UPM-Kymmene Corporation: Managers’ Transactions (Oudeman) UPM-Kymmene Corporation has on 30 April 2020 received the following notification:  Person subject to the notification requirementName: Oudeman, MarjanPosition: Member of the BoardIssuer: UPM-Kymmene CorporationLEI: 213800EC6PW5VU4J9U64 Notification type: INITIAL NOTIFICATION____________________________________________ Transaction date: 2020-04-30Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHARE

Reminder: C-RAD Web Presentation Interim Report Q1 2020

Presentation of the interim report for the first quarter of the fiscal year 2020: Date: Wednesday May 6, 2020 / kl. 11:00 CET Venue: Online Presentation Topic: C-RAD Web Presentation Interim Report Q1 2020 Procedure: Please register online through the website:   https://attendee.gotowebinar.com/register/5849606775349311504 After your registration, you will receive a confirmation via email. A recording of the presentation will be made accessible on the C-RAD website after the presentation. About C-RAD C-RAD develops innovative solutions for use in advanced

Cantargia IND application for CAN04 approved by FDA

Cantargia AB today announced that the IND application regarding the antibody CAN04 has been approved by the US FDA. CAN04, an antibody targeting interleukin 1 receptor accessory protein (IL1RAP), is currently being investigated for treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer (PDAC) in phase IIa clinical development. CAN04 development can now be expanded to the US with a new phase Ib clinical trial investigating CAN04 in combination with immunotherapy in selected cancer forms overexpressing IL1RAP.Cantargia develops antibody-based pharmaceuticals against IL1RAP. The

There are no items matching the current filter
There are no more items matching the current filter
Back to top